Prestige Consumer HealthcarePBH
About: Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Employees: 570
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
76% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 25
12% more repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 105
6% more funds holding
Funds holding: 303 [Q2] → 322 (+19) [Q3]
2% more capital invested
Capital invested by funds: $3.58B [Q2] → $3.64B (+$67.3M) [Q3]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]
2.9% less ownership
Funds ownership: 104.12% [Q2] → 101.21% (-2.9%) [Q3]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
DA Davidson Linda Bolton Weiser 42% 1-year accuracy 36 / 86 met price target | 12%upside $95 | Buy Maintained | 11 Nov 2024 |
Jefferies Stephanie Wissink 50% 1-year accuracy 1 / 2 met price target | 11%downside $76 | Hold Assumed | 24 Sept 2024 |
Financial journalist opinion
Based on 6 articles about PBH published over the past 30 days
